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vidence documenting the clinical value of the minute ventilation (V e)-carbon dioxide output (V co 2 ) relationship, which is commonly expressed as the V e/V co 2 slope, continues to mount in the heart failure (HF) population. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] This noninvasive measure is significantly correlated with aerobic capacity, 1,2,13 cardiac function, 1 and pulmonary perfusion. 8, 14 The V e/V co 2 slope has been shown consistently to be a significant predictor of mortality 4 -7,9,12,15 and hospitalization 3 in patients with HF. Interestingly, the evidence to date has suggested that the V e-V co 2 relationship may be superior to the more established ventilatory expired gas measure peak oxygen output (V o 2 ) in predicting outcome. 3, 4, 7, 12, 16 While evidence demonstrating the clinical value of the V e/V co 2 slope is now robust, investigation into technical aspects, which would help to standardize the expression of this measure, has been lacking. This may be one reason why peak V o 2 , a measure in which the expression is well-standardized, 17, 18 remains the exercise test "gold standard" for assessing prognosis in the HF population. A primary area of debate involves whether to calculate the V e/V co 2 slope using only exercise data prior to the onset of the ventilatory threshold (VT) 15 /acidotic drive to ventilation 6, 12 or to include all data points from the onset of exercise to peak exercise. [3] [4] [5] 7 The hypothesized reason for not using data points beyond the VT is that there is an acidosis-induced dislinearity in the V e-V co 2 relationship and that the inclusion of this portion has no clinical value. Both techniques, however, consistently produce a prognostically significant marker, although a direct comparison of pre-VT/acidotic ventilatory drive and all-inclusive V e/ V co 2 slope calculations has yet to be performed. Moreover, a compelling theoretical rationale for choosing one calculation method over the other has not been proposed. A second area lacking exploration is the effect that different ventilatory expired gas-sampling intervals have on the V e/V co 2 slope calculation and its prognostic value. Previous investigations have been reported using unaveraged (ie, breath-by-breath), 1 10-s, 3, 7, 6 and 30-s 5 averaged sampling intervals to calculate this relationship. Again, while the aforementioned studies have consistently demonstrated the significant prognostic value of the V e/V co 2 slope, the potential for an optimal sampling interval has not been explored.
Addressing these technical issues would lead to standardizing the expression of this variable and potentially to improving its clinical utility. The purpose of the present investigation was to compare the prognostic ability of the V e/V co 2 slope calculated as follows: (1) using data from the initiation of exercise to the point of VT (ie, pre-VT) and from the initiation of exercise to peak exercise; and (2) using different ventilatory expired gas-sampling intervals.
Materials and Methods
One hundred eighty-eight subjects, assessed between March 18, 1993, and October 19, 2001 , were included in the analysis. One hundred eighteen subjects underwent exercise testing and were subsequently observed by the Veterans Affairs Hospital in Palo Alto, CA. The remaining 70 subjects were tested and observed by the HF program at the Medical College of Virginia Hospital in Richmond, VA. Subject groups from both centers were outpatients who were in compensated HF at the time of exercise testing and were therefore considered to be of comparable health. All subjects signed a written informed consent form explaining the purpose for (clinically indicated, research, or both) and risks of exercise testing at both centers. Approval from the appropriate institutional review board was obtained for all subjects undergoing an exercise test as part of a prospective research project. Clinical characteristics of the subjects are listed in Table 1 .
Inclusion criteria consisted of a diagnosis of HF and evidence of systolic and/or diastolic dysfunction by echocardiogram or cardiac catheterization. Subjects with a primary diagnosis of obstructive/restrictive pulmonary disease were excluded from the study. Subjects who received their regular or emergent care at a facility other than those mentioned previously also were excluded. The latter exclusion criteria helped to ensure that end points of interest were not missed. This sample was considered to be a consecutive series of subjects over the specified period of time the data for which were included in the analysis, provided that the inclusion criteria had been met. Selection bias was therefore not a concern at either center.
Equipment Calibration
Ventilatory expired gas analysis was obtained by one of several metabolic systems depending on the clinic and time frame for exercise testing (at the Medical College of Virginia Hospital: Vmax29, SensorMedics, Yorba Linda, CA; Medical College of Virginia Hospital and Veterans Affairs Hospital: CPX-D, Medgraphics, Minneapolis, MN; Veterans Affairs Hospital: CS-100, Schiller, Baar, Switzerland; and Orca Diagnostics, Santa Barbara, CA). The oxygen and carbon dioxide sensors were calibrated using gases with known oxygen, nitrogen, and carbon dioxide concentrations prior to each test. The flow sensor also was calibrated before each test. Testing was not conducted unless the ventilatory expired gas system passed calibration. Both centers followed similar calibration procedures. The basic principles governing the function of modern-day ventilatory expired gas systems are similar. Given that system calibration was conducted prior to each test, equipment bias was not considered to be a limitation.
Testing Procedure and Data Collection
Symptom-limited exercise tests with ventilatory expired gas analysis were performed using either a treadmill or a cycle ergometer. The treadmill was the only mode of exercise used at the Medical College of Virginia Hospital. The Veterans Affairs Hospital likewise used a treadmill in the majority of exercise tests (ie, approximately 90%). The mode of exercise was dependent on equipment availability as opposed to subject characteristics. Furthermore, there is no hypothetical rationale to support the possibility that the relationship between V e and V co 2 is dependent on exercise mode in a given subject. Both centers solely employ ramping protocols for exercise testing in the HF population, which were similar in stage time and incremental workload adjustments. Monitoring consisted of continuous ECG measurements, manual BP measurements, heart rate recordings at every stage via an ECG, and rating of perceived exertion (Borg scale, 6 to 20) at each stage. The testing procedures were explained prior to testing, and subjects were encouraged to give a maximal effort. The intention of explaining the procedures was to alleviate any apprehension a given subject may have had in putting forth a maximal effort. During testing, subjects were given further verbal encouragement to put forth a maximal effort by the clinician conducting the test. Test termination criteria were in accordance with American College of Sports Medicine guidelines. 18 Monitoring and test termination guidelines were similar at both centers. Data for V o 2 , V co 2 , and V e were collected continuously throughout the exercise test. All 188 subjects had these variables, averaged at Ն 10-s intervals, either in hard copy or computerized format. The 10-s averaged V e/V co 2 and V e/V o 2 data were input into a spreadsheet (Excel; Microsoft; Redmond, WA), and the VT was determined by the ventilatory equivalent method. 19 Two separate V e/V co 2 slope calculations were derived, one using data from the initiation of exercise to the point of the VT (ie, pre-VT V e/V co 2 slope), and the other using data from the initiation of exercise to peak exercise (ie, peak V e/V co 2 slope). Fourteen subjects did not demonstrate a detectable VT and were excluded from this analysis. The difference between pre-VT and peak V e/V co 2 slope was also calculated. One hundred and fifty-three subjects had data maintained on the computer in a format permitting four separate V e/V co 2 slope calculations; unaveraged (breath-by-breath), 10-s, 30-s, and 60-s averaged sampling intervals. The V e/V co 2 slope was again determined by inputting V e and V co 2 data for each of the ventilatory expired gas sampling intervals into a spreadsheet (Excel; Microsoft). Only the peak V e/V co 2 slope calculation was used for the comparison of sampling intervals (the rationale in the "Discussion" section). All V e/V co 2 slope calculations were derived via least squares linear regression (ie, y ϭ mx ϩ b, m ϭ slope). To improve the uniformity of the data, the primary investigator (RA) was the sole processor of exercise test data from both centers.
End Points
Subjects were followed up for cardiac-related mortality and hospitalization 2 years following exercise testing via medical chart review. Subjects not regularly observed by the Medical College of Virginia Hospital or the Veterans Affairs Hospital were excluded from the study to help ensure that end points of interest were not overlooked. Cardiac-related mortality was also separately tracked without a 1-year time constraint. Any death or hospital admission that was precipitated by cardiac dysfunction, as per the hospital discharge diagnosis, was considered to be an event. The most common causes of mortality, as per the hospital discharge diagnosis, were cardiac arrest, myocardial infarction, and endstage HF. The most common causes of hospitalization were decompensated HF and coronary artery disease. Subjects in whom mortality was of a noncardiac etiology were treated as censored cases. To ensure uniformity from both centers, the primary investigator (RA) collected all end point data.
Statistical Analysis
Paired t tests were used to compare differences between pre-VT and peak V e/V co 2 slopes. Repeated-measures analysis of variance (ANOVA) with Tukey honest significant difference post hoc testing was used to compare differences among unaveraged, 10-s, 30-s, and 60-s averaged V e/V co 2 slope calculations.
Univariate Cox regression analysis was used to determine the ability of peak V e/V co 2 slope, pre-VT V e/V co 2 slope, pre-VTpeak V e/V co 2 slope difference, and V e/V co 2 slope calculations, using different sampling intervals (ie, unaveraged, 10 s, 30 s, and 60 s), to predict the 1-year cardiac-related hospitalization rate, the 1-year cardiac-related mortality rate, and the overall cardiacrelated mortality rate.
Receiver operating characteristic (ROC) curves were constructed for the V e/V co 2 slope calculations described above. A z test compared the pre-VT to the peak V e/V co 2 slope classification schemes and the four sampling interval classification schemes. 20 The V e/V co 2 slope was assessed as a continuous variable throughout. All statistical tests with a p value of Ͻ 0.05 were considered to be significant.
Results
The mean (Ϯ SD) follow-up time was 27 Ϯ 21 months, and the annual mortality rate was 5.3%. The mean peak V o 2 and respiratory exchange ratio were 16.6 Ϯ 8.0 mL/kg/min and 1.1 Ϯ 0.2, respectively. The mean pre-VT and peak V e/V co 2 slope values were 29.9 Ϯ 6.8 and 32.5 Ϯ 8.0, respectively. The mean difference between these calculations was 2.6 Ϯ 4.1. The difference between the pre-VT and peak V e/V co 2 slope calculations was statistically significant (p Ͻ 0.0001). The ranges for the pre-VT and peak V e/V co 2 slopes were 17.0 to 55.1 and 16.7 to 68.6, respectively. The V e/V co 2 slope, irrespective of the calculation method, was expressed exclusively as a continuous variable in all of the following prognostic assessments.
Univariate Cox regression analysis for the pre-VT V e/V co 2 slope, the peak V e/V co 2 slope, and the pre-VT-peak V e/V co 2 slope difference revealed that all were significant predictors of the overall cardiacrelated mortality rate, the 1-year cardiac-related mortality rate, and the 1-year cardiac-related hospitalization rate (Table 2) .
ROC curve analysis results for the pre-VT and peak V e/V co 2 slope classification schemes are listed in Table 3 . A z test revealed that the peak V e/V co 2 slope classification scheme was superior to the pre-VT V e/V co 2 slope classification scheme for all three end points (p Ͻ 0.0005).
Given the demonstrated prognostic superiority of the peak over the pre-VT V e/V co 2 slope calculation, all data-sampling comparisons were performed using the peak V e/V co 2 slope. The mean values for unaveraged, 10-s, 30-s, and 60-s averaged peak V e/V co 2 slope calculations were 31.8 Ϯ 8.1, 32.7 Ϯ 8.4, 32.7 Ϯ 9.1, and 32.5 Ϯ 8.9, respectively. Repeatedmeasures ANOVA revealed that there was a significant difference among the four calculations (p ϭ 0.005). The unaveraged peak V e/V co 2 slope calculation was significantly less than the other three averaged calculations (p Ͻ 0.05 [Tukey honest significant difference test]), whereas the other methods did not differ from one another.
Univariate Cox regression analysis revealed the unaveraged, 10-s, 30-s, and 60-s averaged peak V e/ V co 2 slope calculations to be significant predictors of the overall cardiac-related mortality rate, the 1-year cardiac-related mortality rate, and the 1-year cardiac-related hospitalization rate (Table 4) .
ROC curve analysis results for the unaveraged, 10-s, 30-s, and 60-s averaged peak V e/V co 2 slope classifications are listed in Table 5 . A z test revealed that the peak V e/V co 2 slope classifications were not significantly different for any of the end points.
Discussion
Previous investigations have supported the prognostic value of both pre-VT 6,12,15 and peak V e/V co 2 slope calculations. [3] [4] [5] 7 Evidence indicating an elevated V e/V co 2 slope, when present in a patient with HF, manifests itself at rest and continues into exercise. 1, 21, 22 The fact that this ventilatory expired gas abnormality occurs early and does not normalize at any point during exercise may be a primary reason why both pre-VT and peak V e/V co 2 slope calculations are significant predictors of outcome. An argument has been raised regarding the calculation of the V e/V co 2 slope using only the linear (pre-VT/ acidosis) portion of the data, since after the VT there is a nonlinear increase in ventilation. The alternative is to express the V e/V co 2 relationship using a best-fit line between all the data points during exercise, since this would include the hyperventilatory response and potentially would produce a relatively higher slope in patients who exhibit, for example, early metabolic acidosis and ventilation/perfusion mismatching.
While both calculations were significant predictors of mortality and hospitalization in the present study, the peak V e/V co 2 slope calculation was clearly a superior predictor compared to its pre-VT counterpart, as indicated by the ROC curve comparisons in Table 3 . The significant prognostic difference between the pre-VT and peak V e/V co 2 slopes prompted the investigators to assess the value of the difference between these measures independently. It was discovered that the greater the increase in V e/V co 2 slope from pre-VT to peak, the worse the outcome for a given subject. The fact that the difference between the pre-VT and the peak V e/ V co 2 slope calculations is in itself a significant predictor of mortality and hospitalization (Table 2) suggests that capturing the physiologic response from VT to peak exercise is clinically important with respect to this measure. Figure 1 illustrate the unique responses of two subjects from this group.
The pre-VT and peak V e/V co 2 slope calculations shown in Figure 1 , top, were identical and fell within the normal range (slope, 26). This subject did not experience a cardiac-related event during the follow-up period (ie, mortality or hospitalization). The pre-VT and peak V e/V co 2 slope calculations shown in Figure 1 , bottom, were, however, significantly different, with the pre-VT calculation falling within normal limits (slope, 27), while the peak calculation was elevated (slope, 37). The subject illustrated in Figure 1 , bottom, died from cardiac complications 4 months following the exercise test. In this instance, the peak V e/V co 2 slope calculation appropriately identified this subject as being at high risk, while the pre-VT calculation did not. Previous evidence has indicated that an elevated V e/V co 2 slope is at least partly attributable to heightened ventilation associated with reduced cardiac output and thus to poor pulmonary perfusion in HF. 8, 14 Reindl et al 1 reported a significant inverse correlation (r ϭ Ϫ0.66) between the V e/V co 2 slope (measured to peak exercise) and cardiac output at rest in a group of patients with HF. One reason that the peak V e/V co 2 slope was a superior predictor of outcome in the present study may be that individuals with poor outcome exhibit further declines in cardiac function and therefore pulmonary perfusion at high levels of exercise (eg, from VT to peak exercise). In this situation, a V e/V co 2 slope calculated to peak exercise would better reflect prognosis because it captures this decline in central function, which is missed by the pre-VT/acidosis expression.
The V e/V co 2 slope is commonly calculated via linear regression, as was the case in this investigation. Figure 1 , bottom, does, however, illustrate the potential for this relationship to become dislinear when calculated to peak exercise in those individuals with poorer prognoses. This finding may support the use of nonlinear regression to better express the V e/ V co 2 slope, although applying such a calculation uniformly would be difficult given that a number of subjects with HF demonstrate a linear response from the onset of exercise to peak exercise. The prognostic superiority of the peak V e/V co 2 slope calculated via Table 3 for abbreviation not used in the text; n ϭ 153. linear regression does, however, support its general use over pre-VT/acidosis calculations, which was a primary objective of this study. Comparing the prognostic efficacy of linear and nonlinear regression techniques is beyond the scope of this investigation and should be an avenue for future research. It has been suggested that breath-by-breath data should be used to calculate the V e/V co 2 slope, given that the greater density of data and greater precision potentially provide a truer reflection of the V e/V co 2 relationship. In clinical practice, few laboratories acquire breath-by-breath data during exercise, and the majority of the prognostic studies have employed various averaged samples to express the V e/V co 2 slope. We observed that the sampling interval chosen for the V e/V co 2 slope had a minimal impact on either the value obtained or its prognostic utility. Repeated-measures ANOVA indicated that the mean breath-by-breath V e/V co 2 slope calculation was slightly, but significantly, less that its averaged counterparts. This difference may be attributed to the inherent fluctuation associated with breathby-breath data compared to averaged calculations. All sampling interval classification schemes were, however, similar in terms of predicting end points ( Table 5 ), suggesting that the difference detected by Figure 1 . Example of the pre-VT and peak V e/V co 2 slope calculations from two subjects in the data set. * ϭ where two lines overlap in top.
repeated-measures ANOVA has an insignificant impact on the prognostic accuracy and clinical value of the V e/V co 2 slope. The data from previous investigations 3, 4, 7, 11 using different sampling intervals to calculate the V e/V co 2 slope may therefore be comparable.
Overall cardiac-related mortality without a defined time period was used as the end point in the present study in order to make it consistent with previous investigations assessing the prognostic utility of the V e/V co 2 slope 5, 6, 12, 15 This was considered important, given that the conception of the present study was partially based on the findings of these investigations. Limiting the end points tracked to a 1-year time period may, however, be clinically optimal given the fluid nature of cardiac function in HF. Because the stability of HF can change quickly, limiting the follow-up period to 1 year makes the results more relevant for clinical practice. A 1-year tracking period may strike a sufficient balance between avoiding outdated information and the economic constraints of multiple exercise tests. Additionally, most research examining the prognostic value of ventilatory expired gas variables has not used hospitalization as an end point. Given that HF is the primary hospital diagnostic-related group among Medicare patients, 23 analysis of the measures predicting hospitalization in this population seems to be warranted. The ability of the V e/V co 2 slope to effectively predict the risk of hospitalization may provide clinicians the unique opportunity to identify high-risk patients, to provide appropriate interventions, to prevent hospitalization, and to reduce the cost of care. Last, it is the author's opinion that the V e/V co 2 slope, being closely related to cardiac function, is a better predictor of cardiac-related events as opposed to all-cause events. Variables from an exercise test should not be viewed as "all-inclusive" predictors. One would not expect an individual with cancer of the liver and normal cardiac function to have an elevated V e/V co 2 slope. While prognosis may be poor, the V e/V co 2 slope would not reflect this.
Enthusiasm for the use of the V e/V co 2 slope has evolved faster than the methodological issues related to it have been clarified. Future investigations should be conducted to confirm or refute the present findings. An avenue for future research may entail the retrospective analysis of the data collected by other institutions that have examined the prognostic ability of the V e/V co 2 relationship in the HF population. 4 -7,11,12,15 Duplication of the methods of the present study should not be difficult given the computerized nature of current metabolic measuring systems. Such investigations will either lend support or challenge the findings of the present study and are needed to reach a consensus on these technical issues. A second area requiring prospective analysis relates to the proposed hypothesis suggesting that a further decline in cardiac function from VT to peak exercise is captured only by a peak V e/V co 2 slope calculation and is the reason for its prognostic superiority compared to the pre-VT method. Establishing a relationship among cardiac function, pulmonary perfusion, and the V e/V co 2 slope at high levels of exercise is required. A prognostic analysis of post-VT changes in cardiac output and pulmonary perfusion also would be useful to determine the mechanism for the superiority of the peak V e/V co 2 slope observed in the present study.
In conclusion, the results of the present study lay the groundwork for standardizing the V e/V co 2 slope. The V e/V co 2 slope, using data from rest to peak exercise, has greater prognostic power than pre-VT data in patients with HF. The ventilatory expired gas sampling interval used for the V e/V co 2 slope calculation appears to have little impact on its prognostic utility. It is hoped that this investigation will compel other groups to perform similar investigations leading to the standardization of the V e/V co 2 slope and to wider clinical application of this measure.
